MWM
SRNE

MinichMacGregor Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

MinichMacGregor Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,002
Closed -$67K – 128
2020
Q1 		$67K Buy
+26,002
New +$74.9K 0.06% 79

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MinichMacGregor Wealth Management's SRNE Position: Q2 2020 in Review

MinichMacGregor Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2020, closing a stake of 26,002 shares — an estimated $67K sold.

MinichMacGregor Wealth Management first reported a position in SRNE in Q1 2020 and held it in 1 quarter. The position peaked at $67K in Q1 2020. 186 funds tracked by Wall St. Rank hold SRNE as of Q2 2020.

  • MinichMacGregor Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 26,002 Sorrento Therapeutics, Inc. shares in Q2 2020, an estimated $67K.
  • MinichMacGregor Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • MinichMacGregor Wealth Management's Sorrento Therapeutics, Inc. position peaked at $67K in Q1 2020.
  • 186 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2020.

Based on MinichMacGregor Wealth Management's 13F filing for Q2 2020, filed 5 Aug 2020.